Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 415 across all filing types
Latest filing 2025-03-17 Annual Report
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 12th fiscal year (2024.01.01 - 2024.12.31) for T&R Biofab. It contains comprehensive sections including company overview, business description, detailed financial statements (audited), management discussion and analysis, and governance information. This structure corresponds to the standard Korean Annual Report (10-K equivalent). FY 2024
2025-03-17 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for T&R Biofab. It contains the agenda for the 12th Annual General Meeting, including financial statement approval, director appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, cash flow) and management's business overview as part of the meeting materials provided to shareholders. While it contains financial data, it is fundamentally a proxy statement/notice for an upcoming shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company T&R Biofab. It details the date, location, and specific agenda items for the upcoming Annual General Meeting (AGM), including the election of directors and auditors. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2025-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically an amendment ('정정신고') to a previous filing. It details changes to stock option grants due to employee resignations. In the context of financial filings, this type of disclosure regarding stock options and capital structure changes falls under general regulatory filings (RNS) as it does not fit into specific categories like Director's Dealing (which is for personal trades) or Share Issue (which is for new capital).
2025-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report). It details changes to previously reported stock option grants due to employee resignations. In the context of financial filings, announcements regarding stock options, capital changes, or equity-based compensation adjustments that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified under general regulatory filings.
2025-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Amendment Report). It details changes to previously reported stock option grants due to employee resignations. In the context of Korean regulatory filings (DART system), this type of disclosure regarding stock option grants and their subsequent amendments falls under general regulatory filings as it does not fit into specific categories like 'Director's Dealing' (which usually refers to personal trades) or 'Share Issue' (which refers to capital changes). Therefore, it is classified as a Regulatory Filing (RNS).
2025-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.